Contrast-induced nephropathy (Pharmacology of X-ray contrast agents)
- Authors: Raptanova V.A1, Speranskaya A.A1, Proshin S.N2
-
Affiliations:
- First St. Petersburg State Medical University
- Saint Petersburg State Pediatric Medical University of Health Ministry of Russia
- Issue: Vol 7, No 1 (2016)
- Pages: 97-105
- Section: Articles
- URL: https://journals.eco-vector.com/pediatr/article/view/2963
- DOI: https://doi.org/10.17816/PED7197-105
- ID: 2963
Cite item
Abstract
Full Text
About the authors
Vladislava A Raptanova
First St. Petersburg State Medical University
Email: vladislavaraptanova@yandex.ru
Doctor-Intern, the Department of Radiology and Radiation Medicine with Division of Rentgenology. State Budget Educational Institution “The First St. Petersburg State Medical University”.
Alexandra A Speranskaya
First St. Petersburg State Medical University
Email: vladislavaraptanova@yandex.ru
MD, PhD, Dr Med Sci, Professo. Department of Radiology and Radiation Medicine with Division of Rentgenology. State Budget Educational Institution “The First St. Petersburg State Medical University”.
Sergei N Proshin
Saint Petersburg State Pediatric Medical University of Health Ministry of Russia
Email: psnjsn@rambler.ru
MD, PhD, Dr Med Sci, Professor, Head of the Department of Pharmacology. St. Petersburg State Pediatric Medical University.
References
- Каюков И. Г. Рентгеноконтрастная нефропатия ГОЭТАР-Медиа. - М., 2009. [Kauykov IG. Radiopaque nephropathy. GOETAR-Mediya. Мoscow; 2009. (In Russ).]
- Aspelin P. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med. 2003;348(6):491-9.doi: 10.1056/nejmoa021833.
- Cigarroa RG, Lange RA, Williams RH. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86(6):649-52. doi: 10.1016/0002-9343(89)90437-3.
- Gleeson T. Contrast-Induced Nephropathy. Buluga¬hapi¬tiya. 2004;183(6):1673-89. doi: 10.2214/ajr.183.6.01831673.
- Hernandez F. Multivariable prediction of renal insufficiency developing after cardiac surgery. Eur Heart J. 2007;28 (Abstract Supplement):454-463.
- Kappel J. Nephrology: 3. Safe drug prescribing for patients with renal insufficiency. 2002;166:473-7.
- Morcos SK. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol. 2004; 59(5):381-9. doi: 10.1016/j.crad.2003.11.005.
- Rezkalla SH. Contrast Nephropathy. 2003;1(4):301-4.
- Solomon RJ. Cardiac Angiography in renally Impaired Patients (CARE) Study. A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease. Circulation. 2007.
- Thomsen HS. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. British J of Radiol. 2003;76(908):513-8. doi: 10.1259/bjr/26964464.
- Thomsen HS, Morcos SK, Erley CM. The ACTIVETrial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol. 2008;43(3):170-8. doi: 10.1097/rli.0b013e31815f3172.